We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
Build-A-Bear
BBW
$462M
| $664K | ﹤0.01% |
49,835
+466
| +0.9% | +$7.29K |
|
2852
Advantage Solutions
ADV
$361M
| $662K | ﹤0.01% |
12,440
-186
| -1% | -$17.1K |
|
|
VNET
2853
VNET Group
VNET
$2.09B
| $660K | ﹤0.01% |
120,000
| – | – |
|
|
RBOT
2854
DELISTED
Vicarious Surgical
RBOT
| $654K | ﹤0.01% |
6,507
-19
| -0.3% | -$2.21K |
|
2855
Cenntro
CENN
$8.43M
| $652K | ﹤0.01% |
1,109
+10
| +0.9% | +$8.56K |
|
2856
Forestar Group
FOR
$1.51B
| $650K | ﹤0.01% |
58,130
-32,155
| -36% | -$426K |
|
2857
Future Fuel
FF
$223M
| $649K | ﹤0.01% |
107,473
-86,546
| -45% | -$597K |
|
|
URG
2858
Ur-Energy
URG
$556M
| $645K | ﹤0.01% |
592,059
+4,640
| +0.8% | +$5.51K |
|
|
VIEW
2859
DELISTED
View, Inc. Class A Common Stock
VIEW
| $643K | ﹤0.01% |
8,004
+82
| +1% | +$9.32K |
|
2860
Wheels Up
UP
$198M
| $642K | ﹤0.01% |
2,795
-2,135
| -43% | -$856K |
|
|
PVBC
2861
DELISTED
Provident Bancorp
PVBC
| $640K | ﹤0.01% |
44,701
-1,610
| -3% | -$23.9K |
|
|
DSKE
2862
DELISTED
Daseke, Inc. Common Stock
DSKE
| $640K | ﹤0.01% |
118,360
+1,213
| +1% | +$7.8K |
|
|
CTLP
2863
DELISTED
Cantaloupe
CTLP
| $638K | ﹤0.01% |
183,312
-2,255
| -1% | -$12.4K |
|
|
CAN
2864
Canaan Creative
CAN
$159M
| $637K | ﹤0.01% |
194,100
+90,800
| +88% | +$331K |
|
2865
Preformed Line Products
PLPC
$2.28B
| $637K | ﹤0.01% |
8,951
-81
| -0.9% | -$5.7K |
|
2866
Groupon
GRPN
$951M
| $634K | ﹤0.01% |
79,621
-234
| -0.3% | -$2.55K |
|
2867
VistaGen Therapeutics
VTGN
$12.8M
| $633K | ﹤0.01% |
19,723
-66
| -0.3% | -$654 |
|
2868
Greene County Bancorp
GCBC
$589M
| $628K | ﹤0.01% |
21,946
| – | – |
|
|
AEVA
2869
Aeva Technologies
AEVA
$1.82B
| $626K | ﹤0.01% |
66,993
-1,337
| -2% | -$21.1K |
|
2870
Arbutus Biopharma
ABUS
$915M
| $623K | ﹤0.01% |
326,140
-1,185
| -0.4% | -$2.79K |
|
|
ITIC
2871
Investors Title Co
ITIC
$547M
| $623K | ﹤0.01% |
4,418
-55
| -1% | -$8.21K |
|
|
USER
2872
DELISTED
UserTesting, Inc.
USER
| $623K | ﹤0.01% |
158,836
-127,490
| -45% | -$627K |
|
2873
CleanSpark
CLSK
$3.16B
| $618K | ﹤0.01% |
194,584
+9,662
| +5% | +$41.8K |
|
2874
Inseego
INSG
$90.5M
| $615K | ﹤0.01% |
29,745
-882
| -3% | -$21.3K |
|
2875
Donegal Group Class A
DGICA
$714M
| $611K | ﹤0.01% |
45,259
-1,983
| -4% | -$29.9K |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.